TD Asset Management Boosts Stake in Biotech Leader Amgen Inc

TD Asset Management Inc recently increased its stake in Amgen Inc by buying an additional 15,810 shares during the second quarter. The fund now owns 420,259 shares of Amgen's stock, which represents a 3.9% increase from the previous quarter. This investment is valued at $152,184,000 and accounts for 0.08% of Amgen's outstanding shares.

TD Asset Management Inc isn't the only large investor to have increased its stake in Amgen. Other notable investors include Vanguard Group Inc, which boosted its holdings by 1.8%, and State Street Corp, which increased its stake by 4.4%. Capital World Investors also grew its holdings in shares of Amgen by 22.9% during the fourth quarter.

Norges Bank purchased a new position in shares of Amgen worth $2,164,162,000 during the last quarter. Hedge funds and other institutional investors own approximately 76.50% of Amgen's stock.